» Articles » PMID: 23954944

Oral Fluid Cannabinoid Concentrations Following Controlled Smoked Cannabis in Chronic Frequent and Occasional Smokers

Overview
Specialty Chemistry
Date 2013 Aug 20
PMID 23954944
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Oral fluid (OF) is an alternative biological matrix for monitoring cannabis intake in drug testing, and drugged driving (DUID) programs, but OF cannabinoid test interpretation is challenging. Controlled cannabinoid administration studies provide a scientific database for interpreting cannabinoid OF tests. We compared differences in OF cannabinoid concentrations from 19 h before to 30 h after smoking a 6.8% THC cigarette in chronic frequent and occasional cannabis smokers. OF was collected with the Statsure Saliva Sampler™ OF device. 2D-GC-MS was used to quantify cannabinoids in 357 OF specimens; 65 had inadequate OF volume within 3 h after smoking. All OF specimens were THC-positive for up to 13.5 h after smoking, without significant differences between frequent and occasional smokers over 30 h. Cannabidiol (CBD) and cannabinol (CBN) had short median last detection times (2.5-4 h for CBD and 6-8 h for CBN) in both groups. THCCOOH was detected in 25 and 212 occasional and frequent smokers' OF samples, respectively. THCCOOH provided longer detection windows than THC in all frequent smokers. As THCCOOH is not present in cannabis smoke, its presence in OF minimizes the potential for false positive results from passive environmental smoke exposure, and can identify oral THC ingestion, while OF THC cannot. THC ≥ 1 μg/L, in addition to CBD ≥ 1 μg/L or CBN ≥ 1 μg/L suggested recent cannabis intake (≤13.5 h), important for DUID cases, whereas THC ≥ 1 μg/L or THC ≥ 2 μg/L cutoffs had longer detection windows (≥30 h), important for workplace testing. THCCOOH windows of detection for chronic, frequent cannabis smokers extended beyond 30 h, while they were shorter (0-24 h) for occasional cannabis smokers.

Citing Articles

Quantitative analysis of cannabinoids and metabolites in oral fluid by volumetric absorptive microsampling combined with UHPLC-HRMS.

Thiebot P, Magny R, Martins P, Houze P, Bloch V, Vorspan F Anal Bioanal Chem. 2024; 417(2):345-360.

PMID: 39625516 DOI: 10.1007/s00216-024-05651-9.


Concentrations of Delta 9-tetrahydrocannabinol (THC) in oral fluid at different time points after use: An individual participant meta-analysis.

MacDonald S, Zhao J Heliyon. 2024; 10(22):e39873.

PMID: 39584120 PMC: 11583706. DOI: 10.1016/j.heliyon.2024.e39873.


"A glimmer of hope" - Perceptions, barriers, and drivers for medicinal cannabis use amongst Australian and New Zealand people with endometriosis.

Sinclair J, Abbott J, Mikocka-Walus A, Ng C, Sarris J, Evans S Reprod Fertil. 2023; .

PMID: 37855429 PMC: 10692678. DOI: 10.1530/RAF-23-0049.


Photochemical Fingerprinting Is a Sensitive Probe for the Detection of Synthetic Cannabinoid Receptor Agonists; toward Robust Point-of-Care Detection.

Andrews R, May B, Hernandez F, Cozier G, Townsend P, Sutcliffe O Anal Chem. 2023; 95(2):703-713.

PMID: 36599091 PMC: 9850351. DOI: 10.1021/acs.analchem.2c02529.


Affinity Assays for Cannabinoids Detection: Are They Amenable to On-Site Screening?.

Puiu M, Bala C Biosensors (Basel). 2022; 12(8).

PMID: 36005003 PMC: 9405638. DOI: 10.3390/bios12080608.


References
1.
Azorlosa J, Greenwald M, Stitzer M . Marijuana smoking: effects of varying puff volume and breathhold duration. J Pharmacol Exp Ther. 1995; 272(2):560-9. View

2.
Moore C, Ross W, Coulter C, Adams L, Rana S, Vincent M . Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays. J Anal Toxicol. 2006; 30(7):413-8. DOI: 10.1093/jat/30.7.413. View

3.
Lowe R, Karschner E, Schwilke E, Barnes A, Huestis M . Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron.... J Chromatogr A. 2007; 1163(1-2):318-27. PMC: 2714866. DOI: 10.1016/j.chroma.2007.06.069. View

4.
Milman G, Barnes A, Schwope D, Schwilke E, Darwin W, Goodwin R . Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clin Chem. 2010; 56(8):1261-9. PMC: 3171507. DOI: 10.1373/clinchem.2009.141853. View

5.
Maurer H, Sauer C, Theobald D . Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. Ther Drug Monit. 2006; 28(3):447-53. DOI: 10.1097/01.ftd.0000211812.27558.6e. View